RankAlpha logo
Back to Rankings

BBOT

BridgeBio Oncology TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
BBOT vs peer average
22/100
BBOT vs. peer average (F vs. C)
Grade spread
B 4 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

OMER is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $689.74M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerOMEROmeros
BBOT
BridgeBio Oncology Therapeutics
OMER
Omeros
Grade
F
D
Momentum
28
10
Value
46
41
Sentiment
-
63
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs OMER

BBOT / OMER
Grade Position
Below peers
BBOT vs. peer average (F vs. C)
22/100
Momentum
28
BBOT
Value
46
BBOT
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BBOT
1
OMER
Omeros Corp Common
D
40/100
-1
2
OCS
Oculis Holding AG Common
F
20/100
Even
3
IMMX
Immix Biopharma Inc Common
B
80/100
-3
4
SGP
SpyGlass Pharma Inc Common
F
20/100
Even
5
GYRE
Gyre Therapeutics Inc Common
B
80/100
-3
OMER is the first peer returned for this comparison set.